Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

cwhitlock's blog

The Many Lives of Levodopa

Monday, January 26, 2015
James Beck, PhD

The start of 2015 has been noteworthy for those with Parkinson’s disease (PD) as two new therapies  — Rytary™ and Duopa™ — were approved by the FDA at the start of January. Both therapies are updates to the gold-standard treatment of carbidopa/levodopa for those with PD. Manufacturers of both therapies hope to have the medications available on pharmacy shelves in the next few months.


mail icon

Subscribe to get the latest news on treatments, research and other updates.